The Royal Pharmaceutical Society (RPS) has combined with the British Medical Association (BMA), the Royal College of GPs (RCGP) and patient group National Voices to ask for a law change.
In the letter sent to secretary of State for Health and Social Care, Matt Hancock, the organisations call for:
“pharmacists to be able to provide a different quantity, strength, formulation or generic version of the same medicine on a prescription, if it is in short supply. It also calls on the Government to work with stakeholders to implement the changes ahead of the end of the UK transition from the EU at the end of this year.”
The authors see the move as practical, and a good use of pharmacists’ skills in making such decisions.
Sandra Gidley, RPS President, said:
“We urgently need this change ahead of the triple whammy of a second wave of coronavirus, the flu season and a potential no-deal Brexit, all of which would again place heavy demands on the medicines supply chain and primary care services. Pharmacists are experts in medicines and need greater flexibility under the law to make simple changes to prescriptions that help patients get the medicines they need when they need them. It makes no sense to have to turn patients away without their medicine when the answer could literally be sitting on the shelf.”
Find out more in the RPS press release.